MoorLDI2 Burns Imager a laser Doppler blood flow imager for the assessment of burn wounds (MTG2)
NICE has developed medical technology guidance on the moorLDI2-BI.
NICE medical technology guidance addresses specific technologies notified to NICE by manufacturers. The ‘case for adoption’ recommendations are based on the claimed advantages of introducing the specific technology compared with current management of the condition. This ‘case’ is reviewed against the evidence submitted and expert advice. If the case for adopting the technology is supported, then the technology has been found to offer advantages to patients and the NHS. The specific recommendations on individual technologies are not intended to limit use of other relevant technologies which may offer similar advantages.
NICE has said that the moorLDI2-BI can be used to help make decisions about treatment in patients when experienced healthcare professionals aren’t sure about how deep the burn wound is or how long it might take to heal. Hospital teams may want to use the moorLDI2-BI because the evidence showed that decisions about whether to use surgery could be made earlier, meaning less time spent in hospital. It could also reduce the size of areas that are operated on, or avoid the need for surgery completely in some patients who otherwise might have had to have surgery.
- MTG2 MoorLDI2 Burns Imager a laser Doppler blood flow imager for the assessment of burn wounds: guidance (web format)
This page was last updated: 22 February 2013
Information for the public
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.